Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
21/10/2020 11:48
Oct 21 (Reuters) - Aptahem AB APTA.TE :
* APTAHEM ENTERS COLLABORATION AGREEMENT WITH GRANZER
REGULATORY
CONSULTING AND SERVICES TO PREPARE FOR CLINICAL STAGE
* BY ENTERING THIS AGREEMENT, CO TAKES NEXT STEP TO PREPARE
FOR
REGULATORY DOCUMENTATION LEADING TO CLINICAL TRIALS REGARDING
THEIR LEAD CANDIDATE APTA-1 FOR TREATMENT OF SEPSIS
* AIM IS TO SUBMIT DOCUMENTATION TO EMA AND FDA IN ORDER TO
GET
REGULATORY SCIENTIFIC ADVISORY MEETINGS WITH AUTHORITIES
Source text for Eikon: ID:nWkrh9Wvq
Further company coverage: APTA.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman